Nov 17 (Reuters) - Endo International Plc ENDP.O :
* Endo announces positive data from phase 2b study of collagenase clostridium histolyticum (cch) in patients with cellulite
* Endo International Plc - statistically significant results (p<0.001) demonstrated on primary composite endpoint and all secondary endpoints Source text for Eikon: Further company coverage: ENDP.O